secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2025-11-21T23:59:59+00:00
Accession:  0001193125-25-290638
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA completes acquisition of LAVA Therapeutics for $1.04/share plus CVRs
-------------------------------------------------------------------------

- Subsequent Offering Period expired Nov 20, 2025; Post-Offer Reorganization effective same day.
- All LAVA shareholders who did not tender receive cash ($1.04/share) and one CVR for future payments.
- XOMA will file LAVA's financial statements and pro forma info in an amendment to this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312525290638/0001193125-25-290638-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312525290638/d65279d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-290638

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer